OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TERT promoter mutations in telomere biology
Barbara Heidenreich, Rajiv Kumar
Mutation Research/Reviews in Mutation Research (2016) Vol. 771, pp. 15-31
Closed Access | Times Cited: 185

Showing 1-25 of 185 citing articles:

Telomeres and Telomere Length: A General Overview
Nalini Srinivas, P. Sivaramakrishna Rachakonda, Rajiv Kumar
Cancers (2020) Vol. 12, Iss. 3, pp. 558-558
Open Access | Times Cited: 234

Understanding the Molecular Genetics of Basal Cell Carcinoma
Cristina Pellegrini, Maria Giovanna Maturo, Lucia Di Nardo, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 11, pp. 2485-2485
Open Access | Times Cited: 217

The landscape of tolerated genetic variation in humans and primates
Hong Gao, Tobias Hamp, Jeffrey M. Ede, et al.
Science (2023) Vol. 380, Iss. 6648
Open Access | Times Cited: 100

The regulations of telomerase reverse transcriptase (TERT) in cancer
Mingdi Liu, Yuning Zhang, Yong‐Ping Jian, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 28

Structure of Telomerase with Telomeric DNA
Jiansen Jiang, Yaqiang Wang, Lukas Sušac, et al.
Cell (2018) Vol. 173, Iss. 5, pp. 1179-1190.e13
Open Access | Times Cited: 146

TERTpromoter mutations are associated with poor prognosis and cell immortalization in meningioma
Sabine Spiegl‐Kreinecker, Daniela Lötsch, Katharina Neumayer, et al.
Neuro-Oncology (2018) Vol. 20, Iss. 12, pp. 1584-1593
Open Access | Times Cited: 120

Telomere Maintenance Mechanisms in Cancer
Tiago Bordeira Gaspar, Ana Sá, José Manuel Lopes, et al.
Genes (2018) Vol. 9, Iss. 5, pp. 241-241
Open Access | Times Cited: 113

Somatic genetic rescue in Mendelian haematopoietic diseases
Patrick Revy, Caroline Kannengiesser, Alain Fischer
Nature Reviews Genetics (2019) Vol. 20, Iss. 10, pp. 582-598
Closed Access | Times Cited: 91

DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets
Ahmad Ozair, Vivek Bhat, Reid S. Alisch, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1342-1342
Open Access | Times Cited: 30

Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches
Giuseppe Palmieri, Maria Colombino, Milena Casula, et al.
Current Oncology Reports (2018) Vol. 20, Iss. 11
Open Access | Times Cited: 61

Emerging mechanisms of telomerase reactivation in cancer
Shalu Sharma, Shantanu Chowdhury
Trends in cancer (2022) Vol. 8, Iss. 8, pp. 632-641
Open Access | Times Cited: 35

TERT Promoter Mutations and Telomerase in Melanoma
Yuchen Guo, Yi Chen, Lianghui Zhang, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 29

Genetic and clinical determinants of telomere length
Patrick D. Allaire, Jing He, John E. Mayer, et al.
Human Genetics and Genomics Advances (2023) Vol. 4, Iss. 3, pp. 100201-100201
Open Access | Times Cited: 18

Molecular diversity in IDH-wildtype glioblastoma
Jawad Fares, Yizhou Wan, Richard Mair, et al.
Brain Communications (2024) Vol. 6, Iss. 2
Open Access | Times Cited: 8

Structural basis for reactivating the mutant TERT promoter by cooperative binding of p52 and ETS1
Xueyong Xu, Yinghui Li, S.R. Bharath, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 57

TERT promoter mutation subtypes and survival in stage I and II melanoma patients
Juan José Andrés Lencina, P. Sivaramakrishna Rachakonda, Zaida García‐Casado, et al.
International Journal of Cancer (2018) Vol. 144, Iss. 5, pp. 1027-1036
Open Access | Times Cited: 49

Pathogenic TERT promoter variants in telomere diseases
Fernanda Gutierrez‐Rodrigues, Flávia S. Donaires, André Luiz Pinto Santos, et al.
Genetics in Medicine (2018) Vol. 21, Iss. 7, pp. 1594-1602
Open Access | Times Cited: 47

Non-duplex G-Quadruplex DNA Structure: A Developing Story from Predicted Sequences to DNA Structure-Dependent Epigenetics and Beyond
Antara Sengupta, Shuvra Shekhar Roy, Shantanu Chowdhury
Accounts of Chemical Research (2020) Vol. 54, Iss. 1, pp. 46-56
Open Access | Times Cited: 46

POT1-TPP1 telomere length regulation and disease
Tomas M. Aramburu, Sarah M. Plucinsky, Emmanuel Skordalakes
Computational and Structural Biotechnology Journal (2020) Vol. 18, pp. 1939-1946
Open Access | Times Cited: 42

Detecting recurrent passenger mutations in melanoma by targeted UV damage sequencing
Kathiresan Selvam, Smitha Sivapragasam, Gregory M.K. Poon, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15

Genetic alterations in seborrheic keratoses
Barbara Heidenreich, Evgeniya Denisova, P. Sivaramakrishna Rachakonda, et al.
Oncotarget (2017) Vol. 8, Iss. 22, pp. 36639-36649
Open Access | Times Cited: 45

Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk
P. Sivaramakrishna Rachakonda, Hai-ying Kong, Nalini Srinivas, et al.
Genes Chromosomes and Cancer (2018) Vol. 57, Iss. 11, pp. 564-572
Closed Access | Times Cited: 45

Aberrant expression of ETS1 and ETS2 proteins in cancer
Elizabeth A. Fry, Kazushi Inoue
Cancer Reports and Reviews (2018) Vol. 2, Iss. 3
Open Access | Times Cited: 41

Conjunctival Melanoma: Genetic and Epigenetic Insights of a Distinct Type of Melanoma
Ernesto Rossi, Giovanni Schinzari, Brigida Anna Maiorano, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 21, pp. 5447-5447
Open Access | Times Cited: 41

Page 1 - Next Page

Scroll to top